Gulsen Hazirolan

Dr. Gulsen Hazirolan


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2022 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
AAAbdullah Tarik Aslan
Abdullah Tarik Aslan
EKEkin Kırbaş
Ekin Kırbaş
BSBanu Sancak
Banu Sancak
ETElif Seren Tanriverdi
Elif Seren Tanriverdi
BOBarış Otlu
Barış Otlu
Murat AkovaMurat Akova
Murat Akova

25 May 2022 in Mycoses
Verified
Journal Article
Closed access
BEBerrin Er
Berrin Er
AEAhmet Görkem Er
Ahmet Görkem Er
Dolunay GülmezDolunay Gülmez
Dolunay Gülmez
TŞTaha Koray Şahin
Taha Koray Şahin
BHBurçin Halaçlı
Burçin Halaçlı
ÖUÖmrüm Uzun
Ömrüm Uzun

1 September 2018 in Journal of Medical Mycology
Verified
Journal Article
Closed access
GHGulsen Hazirolan
Gulsen Hazirolan
NKN. Koçak
N. Koçak
AKA. Karagöz
A. Karagöz

1 January 2018 in Nigerian Journal of Clinical Practice
Verified
Journal Article
Open access
GHGulsen Hazirolan
Gulsen Hazirolan
IMI Mumcuoglu
I Mumcuoglu
GAG Altan
G Altan
BÖBb Özmen
Bb Özmen
NAN Aksu
N Aksu
ZKZc Karahan
Zc Karahan
Investigate cefotaxime-M (CTX-M) genes among ESBL isolates. Materials and Methods: A total of 1402 fecal specimens which were collected from outpatients included in the study. ESBL screening, ESBL production, and AmpC beta-lactamase detection were performed. Matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) was used for identification of species. Antibiotic susceptibilities of the isolates were detected by disk diffusion method. CTX-M beta-lactamase genes were investigated by polymerase chain reaction. Results: During the study period, a total of 1402 fecal samples were analysed with ESBL screening test and 490 Enterobacteriaceae strains isolated from these samples (Escherichia coli [n = 461, 94.1%], Klebsiella pneumoniae [n = 25, 5.1%], and Enterobacter cloacae [n = 4, 0.8%]). Fecal carriage of ESBL-producing Enterobacteriaceae in the community was 34.3%. AmpC beta-lactamases were detected in 26 (5.3%), and the frequency of CTX-M was found as 96.9%. The resistance rates of the E. coli strains to fluoroquinolones, trimethoprim–sulfamethoxazole, and carbapenems were 31.2%, 33.3%, and 0%, respectively. Conclusion: The relative high prevalence of fecal carriage of ESBL-producing bacteria in community warrants further study in this field including developing policies about antimicrobial use and close monitoring of resistance patterns....

1 September 2017 in Journal of Medical Mycology
Verified
Journal Article
Closed access
GHGulsen Hazirolan
Gulsen Hazirolan
HAH.U. Altun
H.U. Altun
RGRamazan GÜMRAL
Ramazan GÜMRAL
NGN.C. Gursoy
N.C. Gursoy
BOBarış Otlu
Barış Otlu
BSB. Sancak
B. Sancak

21 December 2022 in Microbiology Spectrum
Verified
Journal Article
Open access
KAKholod Khalil Al-Manei
Kholod Khalil Al-Manei
MGMahin Ghorbani
Mahin Ghorbani
SNSabrina Naud
Sabrina Naud
KAKholod Khalil Al-Manei
Kholod Khalil Al-Manei
MSMichał J. Sobkowiak
Michał J. Sobkowiak
VÖVolkan Özenci
Volkan Özenci
Oral diseases and associated microbes are a risk factor for systemic diseases and can change the courses of these diseases. To date, epidemiological data on microbial oral infections are scarce, and longitudinal reports are lacking.